Development of a competitive enzyme-linked immunosorbent assay for therapeutic drug monitoring of afatinib.
Afatinib
Enzyme-linked immunosorbent assay
Therapeutic drug monitoring
Tyrosine-kinase inhibitor
Journal
Journal of pharmaceutical analysis
ISSN: 2214-0883
Titre abrégé: J Pharm Anal
Pays: China
ID NLM: 101579451
Informations de publication
Date de publication:
Feb 2019
Feb 2019
Historique:
received:
30
03
2018
revised:
31
07
2018
accepted:
17
09
2018
entrez:
12
2
2019
pubmed:
12
2
2019
medline:
12
2
2019
Statut:
ppublish
Résumé
Afatinib is an oral tyrosine kinase inhibitor (TKI) approved for treating advanced non-small cell lung cancer. It is necessary to develop a simple quantification method for TKIs in order to facilitate therapeutic drug monitoring (TDM) in clinical settings. This study sought to develop a simple and sensitive competitive enzyme-linked immunosorbent assay (ELISA) to quantify afatinib in plasma for routine pharmacokinetic applications. An anti-afatinib antibody was obtained using (S)-
Identifiants
pubmed: 30740257
doi: 10.1016/j.jpha.2018.09.002
pii: S2095-1779(18)30308-3
pmc: PMC6355467
doi:
Types de publication
Journal Article
Langues
eng
Pagination
49-54Références
Pharm Res. 1992 Nov;9(11):1375-9
pubmed: 1475221
Cancer Chemother Pharmacol. 2012 Apr;69(4):1051-61
pubmed: 22200729
Mol Immunol. 1990 Oct;27(10):995-1000
pubmed: 2233759
Lancet Oncol. 2012 May;13(5):539-48
pubmed: 22452895
J Clin Oncol. 2013 Sep 20;31(27):3327-34
pubmed: 23816960
Drugs. 2013 Sep;73(13):1503-15
pubmed: 23982599
Biol Pharm Bull. 2013;36(12):1964-8
pubmed: 24292055
Ther Drug Monit. 2014 Feb;36(1):24-9
pubmed: 24413624
Clin Pharmacokinet. 2014 Apr;53(4):305-25
pubmed: 24566736
Lung Cancer. 2015 Apr;88(1):74-9
pubmed: 25704957
J Sep Sci. 2015 Aug;38(16):2781-8
pubmed: 26017356
Lancet Oncol. 2015 Aug;16(8):897-907
pubmed: 26156651
Biol Pharm Bull. 2015;38(10):1652-7
pubmed: 26424026
Biol Pharm Bull. 2015;38(11):1788-93
pubmed: 26521829
Biomed Chromatogr. 2016 Aug;30(8):1248-55
pubmed: 26683307
Oncol Lett. 2016 Aug;12(2):1223-1232
pubmed: 27446421
Clin Pharmacokinet. 2017 Mar;56(3):235-250
pubmed: 27470518
Ann Oncol. 2016 Nov;27(11):2103-2110
pubmed: 27601237
J Chromatogr B Analyt Technol Biomed Life Sci. 2016 Oct 15;1033-1034:390-398
pubmed: 27639128
Anal Chim Acta. 2017 May 29;969:72-78
pubmed: 28411632
J Pharm Anal. 2018 Apr;8(2):119-123
pubmed: 29736298
Anal Biochem. 1966 Mar;14(3):328-36
pubmed: 4161471
Chem Pharm Bull (Tokyo). 1981 Jan;29(1):170-5
pubmed: 7020966